Head and neck paragangliomas
- 4 November 2010
- journal article
- review article
- Published by Wiley in Head & Neck
- Vol. 33 (10), 1530-1534
- https://doi.org/10.1002/hed.21524
Abstract
Background The purpose of this study was to describe the natural history and optimal treatment for head and neck paragangliomas (PGs). Methods Our methods were the review of the pertinent literature. Results PGs are rare tumors seen most commonly in the head and neck. Approximately 90% are sporadic; the remainder are familial and related to mutations of the succinate dehydrogenase (SDH) gene complex. Most PGs are benign and slow growing; 6% to 19% are malignant, as evidenced by the development of metastases. PGs may be treated by complete resection or moderate‐dose radiotherapy with a ≥90% likelihood of cure. The optimal radiotherapy dose is approximately 45 Gy/25 fractions/5 weeks. The treatment modality selected depends on the risk of complications. Due to their rarity, the optimal treatment for malignant PGs is unclear. Conclusion PGs may be treated by either complete resection or radiotherapy with a high likelihood of success. Treatment depends on the location and extent of the PG and the morbidity associated with treatment. © 2010 Wiley Periodicals, Inc. Head Neck, 2010Keywords
This publication has 20 references indexed in Scilit:
- The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with ParagangliomasJournal of Clinical Endocrinology & Metabolism, 2009
- Paraganglioma of the Head and NeckAmerican Journal of Clinical Oncology, 2009
- Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-OutCancer Research, 2009
- Management of head and neck paragangliomas: Review of 120 patientsHead & Neck, 2009
- Definitive radiotherapy in the management of paragangliomas arising in the head and neck: A 35‐year experienceHead & Neck, 2008
- Screening for familial paragangliomasOral Oncology, 2008
- High Frequency of Germline Succinate Dehydrogenase Mutations in Sporadic Cervical Paragangliomas in Northern Spain: Mitochondrial Succinate Dehydrogenase Structure-Function Relationships and Clinical-Pathological CorrelationsJournal of Clinical Endocrinology & Metabolism, 2007
- The genetics of paragangliomas: a reviewClinical Otolaryngology, 2007
- Cervical Paragangliomas-Tumor Control and Long-Term Functional Results after SurgeryJournal of Neurological Surgery Part B: Skull Base, 2006
- Distinct Clinical Features of Paraganglioma Syndromes Associated With SDHB and SDHD Gene MutationsPublished by American Medical Association (AMA) ,2004